Today: 9 June 2026
CoreWeave stock (CRWV) slips after-hours as CEO bats away Nvidia ‘circular financing’ fears
14 January 2026
1 min read

CoreWeave stock (CRWV) slips after-hours as CEO bats away Nvidia ‘circular financing’ fears

NEW YORK, Jan 13, 2026, 19:44 EST — After-hours

CoreWeave Inc shares slipped 2.7% to $87.48 in after-hours trading Tuesday, trimming gains that had recently drawn momentum traders back in.

This matters since CoreWeave now stands as a rough benchmark for the leveraged AI infrastructure play: fast growth fueled by significant debt. When interest rates move or credit concerns arise, shares tied to large data-center investments tend to swing sharply.

CoreWeave purchases Nvidia graphics processing units, or GPUs—chips that power AI system training and operations—and leases out that computing capacity to clients. Some critics doubt these GPUs retain enough value over time to back the company’s financing approach.

On the Big Technology Podcast, CEO Michael Intrator dismissed the “circular financing” claim—that Nvidia backs CoreWeave mainly to boost chip sales—as “ridiculous.” He noted Nvidia’s investment totaled roughly $300 million over two rounds, compared to CoreWeave’s more than $25 billion raised overall and a $42 billion valuation. Intrator also defended Nvidia’s use of special purpose vehicles, which isolate risk through separate financing “boxes.” Chief Strategy Officer Brian Venturo added that the company recently renewed a contract for older Nvidia A100 chips at about 95% of their initial price.

Goldman Sachs kicked off coverage of CoreWeave on Monday, tagging it with a Neutral rating and setting an $86 price target, according to an Investing.com report. The bank highlighted execution risks and warned about the strain a hefty debt burden could place on a company that still has to ramp up capacity under tight deadlines.

Rate-sensitive growth stocks found some backing Tuesday morning after U.S. data revealed consumer prices climbed 0.3% in December, in line with forecasts. This has kept hopes alive that the Federal Reserve might hold rates steady at its upcoming meeting later this month. Even so, investors remain quick to offload gains in higher-debt companies.

CoreWeave’s immediate challenge isn’t headline demand but the nuts and bolts: deliveries, how well they use capacity, and financing costs. Investors treat the stock as a test of whether “AI capex” actually converts into timely cash flow.

The downside is clear. Delays in launching new power and data-center capacity, or a drop in customer spending, could delay cash inflows and raise refinancing costs—especially if hardware prices decline more quickly than anticipated.

Traders are closely watching Wednesday’s U.S. retail sales report due at 8:30 a.m. ET, with the Fed’s policy meeting on Jan. 27-28 looming as well. Both events could offer clues on growth and interest rates, key factors influencing appetite for debt-heavy AI infrastructure stocks.

Stock Market Today

  • Designer Brands (DBI) Beats Q1 Earnings and Revenue Estimates
    June 9, 2026, 10:04 AM EDT. Designer Brands (DBI) reported Q1 earnings of $0.07 per share, surpassing the Zacks estimate of $0.02 and reversing a year-ago loss of $0.26. Revenue hit $696.35 million, just above the $696 million consensus. The company delivered a 250% earnings surprise and has beaten EPS estimates in four consecutive quarters. Shares rose about 19.5% year-to-date, outpacing the S&P 500's 8.2% gain. Despite strong results, the stock holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market. The Retail - Apparel and Shoes sector ranks among the top three industries. Future stock performance will depend on management's outlook and upcoming earnings estimate revisions, with current consensus estimates at $0.30 EPS on $744 million revenue next quarter and $0.35 EPS on $2.91 billion revenue for the fiscal year.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Google stock (GOOG) rises after-hours on Apple’s Gemini-Siri deal as earnings near
Previous Story

Google stock (GOOG) rises after-hours on Apple’s Gemini-Siri deal as earnings near

BHP stock ends higher as China’s iron ore surge meets merger talk — what’s next for ASX:BHP
Next Story

BHP stock ends higher as China’s iron ore surge meets merger talk — what’s next for ASX:BHP

Go toTop